In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (Skin, ADME, Organ Toxicity, Genotoxicity), Technology (HTS, Cell-based), Industry (Cosmetics, Pharmaceutical), Method (Ex-Vivo, Cellular Assays) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: June 2, 2019
Clear
SKU: GMS844 Category:

The global market for in vitro toxicology research is projected to reach USD 12.73 billion by 2024, with a CAGR growth of 9.27% over the forecast period. Growth in this market is primarily driven by opposition to animal testing, technological advances and increased spending on R&D to detect toxicity at an early stage during drug development.

In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (Skin, ADME, Organ Toxicity, Genotoxicity), Technology (HTS, Cell-based), Industry (Cosmetics, Pharmaceutical), Method (Ex-Vivo, Cellular Assays) - 2019 to 2024 1

In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (Skin, ADME, Organ Toxicity, Genotoxicity), Technology (HTS, Cell-based), Industry (Cosmetics, Pharmaceutical), Method (Ex-Vivo, Cellular Assays) - 2019 to 2024 2

In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (Skin, ADME, Organ Toxicity, Genotoxicity), Technology (HTS, Cell-based), Industry (Cosmetics, Pharmaceutical), Method (Ex-Vivo, Cellular Assays) - 2019 to 2024 3

In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (Skin, ADME, Organ Toxicity, Genotoxicity), Technology (HTS, Cell-based), Industry (Cosmetics, Pharmaceutical), Method (Ex-Vivo, Cellular Assays) - 2019 to 2024 4

In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (Skin, ADME, Organ Toxicity, Genotoxicity), Technology (HTS, Cell-based), Industry (Cosmetics, Pharmaceutical), Method (Ex-Vivo, Cellular Assays) - 2019 to 2024 5

In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (Skin, ADME, Organ Toxicity, Genotoxicity), Technology (HTS, Cell-based), Industry (Cosmetics, Pharmaceutical), Method (Ex-Vivo, Cellular Assays) - 2019 to 2024 6

In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (Skin, ADME, Organ Toxicity, Genotoxicity), Technology (HTS, Cell-based), Industry (Cosmetics, Pharmaceutical), Method (Ex-Vivo, Cellular Assays) - 2019 to 2024 7

In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (Skin, ADME, Organ Toxicity, Genotoxicity), Technology (HTS, Cell-based), Industry (Cosmetics, Pharmaceutical), Method (Ex-Vivo, Cellular Assays) - 2019 to 2024 8

1 Global In-Vitro Toxicology/Toxicity Testing Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global In-Vitro Toxicology/Toxicity Testing Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global In-Vitro Toxicology/Toxicity Testing Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global In-Vitro Toxicology/Toxicity Testing Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global In-Vitro Toxicology/Toxicity Testing Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global In-Vitro Toxicology/Toxicity Testing Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global In-Vitro Toxicology/Toxicity Testing Market – By Product & Service (Market Size – & million/billion)
8.1 Consumables
8.2 Assays
8.3 Equipment
8.4 Software
8.5 Services

9 Global In-Vitro Toxicology/Toxicity Testing Market – By Method
9.1 Cellular Assays
9.2 Biochemical Assays
9.3 In Silico Models
9.4 Ex Vivo Models

10 Global In-Vitro Toxicology/Toxicity Testing Market – By Technology
10.1 Cell Culture Technologies
10.2 High-throughput Technologies
10.3 Toxicogenomics

11 Global In-Vitro Toxicology/Toxicity Testing Market – By Toxicity Endpoint
11.1 Cellular Assays
11.2 Biochemical Assays
11.3 In Silico Models
11.4 Ex Vivo Models
11.5 Others

12 Global In-Vitro Toxicology/Toxicity Testing Market – By End-User
12.1 Cellular Assays
12.2 Biochemical Assays
12.3 In Silico Models
12.4 Ex Vivo Models

13 Global In-Vitro Toxicology/Toxicity Testing Market – By Geography (Market Size – & million/billion)
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 U.K
13.3.2 Germany
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 South Korea
13.4.5 Rest of APAC
13.5 Rest of the World
13.5.1 South America
13.5.2 Middle East
13.5.3 Africa

14 Global In-Vitro Toxicology/Toxicity Testing Market – Entropy
14.1 New product launches
14.2 M&A’s, collaborations, JVs and partnerships

15 Global In-Vitro Toxicology/Toxicity Testing Market Company Profile (Key Players)
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Thermo Fisher Scientific, Inc.
15.3 GE Healthcare
15.4 Merck KGaA
15.5 SGS S.A.
15.6 Eurofins Scientific Se
15.7 Qiagen N.V.
15.8 Cyprotex PLC
15.9 Charles River Laboratories International, Inc.
15.10 Promega Corporation
15.11 Bio-Rad Laboratories, Inc.
15.12 Company 11 & more

16 Global In-Vitro Toxicology/Toxicity Testing Market – Appendix
16.1 Sources
16.2 Abbreviations